Integrity Alliance LLC. Buys New Position in Stereotaxis Inc. $STXS

Integrity Alliance LLC. acquired a new position in Stereotaxis Inc. (NYSEAMERICAN:STXS) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 699,023 shares of the company’s stock, valued at approximately $860,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Sequoia Financial Advisors LLC acquired a new position in Stereotaxis during the 1st quarter worth about $700,000. Bank of New York Mellon Corp bought a new position in Stereotaxis during the 2nd quarter valued at $364,000. Finally, Sei Investments Co. increased its stake in Stereotaxis by 108.9% during the 1st quarter. Sei Investments Co. now owns 518,884 shares of the company’s stock valued at $955,000 after buying an additional 270,443 shares during the period. Institutional investors and hedge funds own 45.35% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on STXS shares. Citigroup reissued an “outperform” rating on shares of Stereotaxis in a report on Thursday, August 27th. TD Cowen cut their price target on shares of Stereotaxis from $5.00 to $3.00 and set a “buy” rating on the stock in a research report on Wednesday, August 12th. Finally, Citizens Jmp lowered their target price on Stereotaxis from $4.00 to $3.00 and set a “market outperform” rating on the stock in a research note on Thursday, August 27th. Five research analysts have rated the stock with a Buy rating. According to MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $3.38.

Stereotaxis Stock Up 3.8%

STXS opened at $1.09 on Friday. The company has a market cap of $109.22 million, a price-to-earnings ratio of -4.54 and a beta of 1.40. The firm’s fifty day simple moving average is $1.17 and its two-hundred day simple moving average is $1.67. Stereotaxis Inc. has a 52-week low of $0.80 and a 52-week high of $2.89.

Stereotaxis (NYSEAMERICAN:STXS) last announced its earnings results on Tuesday, August 11th. The company reported ($0.05) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.05). Stereotaxis had a negative return on equity of 130.84% and a negative net margin of 74.24%. The firm had revenue of $7.67 million during the quarter, compared to analysts’ expectations of $8.35 million. On average, research analysts forecast that Stereotaxis Inc. will post -0.22 EPS for the current year.

Stereotaxis Company Profile

Stereotaxis, Inc develops robotic technologies for minimally invasive endovascular procedures, with a primary focus on cardiac electrophysiology. Its systems use magnetic navigation and specialized software to help physicians control guidewires and catheters during procedures such as the treatment of cardiac arrhythmias.

The company’s product portfolio includes the Genesis Robotic Magnetic Navigation System, which is designed to provide precise catheter movement and navigation within the heart.